Olverembatinib (GZD824) dimesylate

Ask supplier a question | View on supplier's website

Olverembatinib (GZD824) dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Supplier	Selleck Chemicals
Product #	S7194
Sku #	S7194-25mg
Pricing	25mg, $570.00

Feedback